Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort Turbuhaler vs Seretide Diskus in severe COPD and healthy volunteers
2006-002412-10Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of budesonide, salmeterol + fluticasone and fluticasone propionate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by AstraZeneca. Primary endpoints: Area under the curve (AUC) of fluticasone plasma concentrations and Area under the curve (AUC) of budesonide plasma concentrations. Started Apr 2007; status: completed.
02
Drugs
budesonidesalmeterol + fluticasonefluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-002412-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002412-10.